Effects of tacrine on deficits in active avoidance performance induced by AF64A in rats.

This publication has 25 references indexed in Scilit:

• Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
  Proceedings of the National Academy of Sciences, 1996
• Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Molecular strategies for the first generations of antidementia drugs. (I). Tacrine and related compounds
  Drugs of Today, 1994
• Tacrine: A pharmacological review
  Progress in Neurobiology, 1991
• Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A)
  Brain Research, 1989
• (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
  Neuroscience Letters, 1989
• Behavioural and histological effects of low concentrations of intraventricular AF64A
  European Journal of Pharmacology, 1989
• Effects of intrahippocampal injections of the cholinergic neurotoxin AF64A on open-field activity and avoidance learning in the rat
  Behavioral and Neural Biology, 1986
• Potential Animal Models for Senile Dementia of Alzheimer's Type, with Emphasis on AF64A-Induced Cholinotoxicity
  Annual Review of Pharmacology and Toxicology, 1986
• Choline analogs as potential tools in developing selective animal models of central cholinergic hypofunction
  Life Sciences, 1980